Stockreport

FDA approves Epizyme's treatment for rare tissue cancer [Reuters]

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com
PDF FDA approves Epizyme's treatment for rare tissue cancer (Reuters) - The U.S. Food and Drug Administration has approved Epizyme Inc’s treatment for a rare, slow growing t [Read more]